Smart For Life, Inc. (SMFL) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2022

SEC Filings

SMFL Quarterly Reports

    10-Q Quarterly Report November 2022
  • 10-Q Quarterly Report August 2022
  • 10-Q Quarterly Report May 2022

Smart For Life, Inc.

CIK: 1851860 Ticker: SMFL

Exhibit 99.1




Smart for Life Announces Q1 2022 Financial Results


Company Achieves 679% Year-Over-Year Revenue Growth
as Part of Successful Acquisition Strategy


Gross Profit Margin Increases to 34.1% Versus
3.7% for the Same Period Last Year


Miami, FL – May 16, 2022 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading developer, marketer, and manufacturer of nutritional and related products, today provided a business update and reported financial results for the first quarter ended March 31, 2022.


“I am pleased to report we achieved significant growth in revenue as a result of both organic growth and the successful implementation of our acquisition strategy, to $4.5 million this quarter,” stated Darren Minton, Chief Executive Officer of Smart for Life. “By acquiring three companies, including Doctors Scientific Organica (DSO), Nexus Offers (Nexus) and GSP Nutrition (GSP) since the same period last year, we were able to significantly expand our product lines, production capabilities, distribution, and marketing capabilities.”


In the first quarter ended March 31, 2022, Smart for Life generated 679% year-over-year growth in revenue to $4.5 million. In addition, gross profit increased more than seventy-fold to $1.5 million for the first quarter ended March 31, 2022, as compared to just $21 thousand for the first quarter ended March 31, 2021. Similarly, the Company’s gross margin increased to 34.1% from 3.7% for the same quarter last year. The increase in the gross profit and gross margin reflects both the improved product mix, as well as lower cost of materials due to increased purchasing power.


“It is important to note that our operating expenses included one-time, non-cash interest expense of $11.2 million related to equity issued at the time of the IPO, as well as other non-cash expenses of $1.2 million,” remarked Mr. Minton. “We also incurred significant costs of $0.7 million this quarter related to the IPO and public company costs we did not have last year. As a result, we believe future quarters will better reflect the true operating synergies of our business model. We believe we will start to see improvement in future quarters as we consolidate operations, eliminate duplicate costs and grow our various operating units. Overall, we believe we have built a highly scalable business model and expect to benefit from improved operating efficiency as we leverage our fixed costs, which should result in significant profitability as we continue to grow revenues.”


“Through accretive acquisitions, our goal is to achieve $100 million in revenues within the next 24 months,” commented A.J. Cervantes, Jr., Smart for Life’s Executive Chairman. “Towards that end, we announced a definitive agreement to acquire Ceautamed Worldwide, a premier vitamin and supplement company that markets and distributes a wide variety of nutritional products, including antioxidant rich supplements, plant-based protein, alkalizing nutrients and products designed for weight management. Their Greens First brand is widely acknowledged as one of the best true greens powders on the market. Ceautamed fits nicely within our growing brand portfolio, and our strategy is to accelerate Ceautamed’s growth by leveraging our distribution relationships and digital marketing platform, in addition to migrating their manufacturing to our wholly owned, state-of-the-art manufacturing facility, which will result in immediate cost savings.”





Mr. Minton continued, “We are also advancing plans related to GSP Nutrition’s Sports Illustrated Nutrition™ brand for certain dietary and nutritional supplements. Our product line already includes a growing roster of high quality products, such as whey protein powder, joint health, pre- and post-workout blends, omega-3 supplements, and more. We believe the tremendous brand recognition associated with Sports Illustrated will enable us to rapidly expand into new retail and online marketing channels. Towards this end, we look forward to providing further updates as developments unfold.”


“During the quarter, we announced that we expanded our sales channels by launching the DSO brand on Amazon Singapore. Smart for Life was selected by Amazon to introduce several of its key SKUs into Amazon’s storefront in Singapore. This launch represents a significant new market for Smart for Life and enhances our existing international sales in Canada, Mexico and overseas. We have made tremendous progress in the first quarter by growing our business through acquisitions and are well positioned to execute on a number of key milestones that we believe will drive significant value for shareholders,” concluded Mr. Minton.


Financial Results


Revenues increased to $4.5 million in Q1 2022 compared to $0.6 million for Q1 2021, an increase of $3.9 million or 679%. The increase was primarily due to the acquisitions of DSO, Nexus and GSP that were completed in 2021. Gross profit increased to $1.5 million in Q1 2022 compared to $0.02 million same period last year, an increase of $1.5 million due to the acquisitions completed in 2021. Net loss attributable to common shareholders was $16.7 million in Q1 2022 compared to $0.8 million in Q1 2021 primarily due to increased general and administrative expenses of $4.4 million and total other expense of $13.3 million.


The Company reported Adjusted EBITDA of ($2.8) million in Q1 2022, as compared to Adjusted EBITDA of ($0.6 million) for Q1 2021. The Company defines EBITDA as earnings before interest, taxes and depreciation and amortization. Adjusted EBITDA is defined as EBITDA before other expense and day 1 loss and changes in fair value of derivative liability. Both EBITDA and Adjusted EBITDA are not measures of performance calculated in accordance with Generally Accepted Accounting Principles in the United States of America (“GAAP”), and should not be considered in isolation of, or as a substitute for, earnings as an indicator of operating performance or cash flows from operating activities as a measure of liquidity. The Company believes the presentation of EBITDA and Adjusted EBITDA is relevant and useful by enhancing the readers’ ability to understand the Company’s operating performance. The Company’s management utilizes EBITDA and Adjusted EBITDA as means to measure performance. The Company’s measurements of EBITDA and Adjusted EBITDA may not be comparable to similar titled measures reported by other companies. The table below reconciles EBITDA and Adjusted EBITDA, both non-GAAP measures, to GAAP numbers for net loss for the three months ended March 31, 2022 and 2021.


   Q1 2022   Q1 2021 
Net Loss  $(16,574,477)  $(780,641)
Interest   12,757,479    74,840 
Taxes   -    - 
Depreciation and amortization   423,010    54,008 
EBITDA   (3,393,988)   (651,793)
Other expense   506,133    7,797 
Day 1 loss and changes in fair value of derivative liability   38,997    - 
Adjusted EBITDA  $(2,848,858)  $(643,996)





About Smart for Life, Inc.


Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a global holding company, the Company is executing a buy-and-build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-six months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates four subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing and GSP Nutrition. For more information about Smart for Life, please visit:


A video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at:


Investor material and a Fact Sheet with additional information about Smart for Life is available at:


Forward-Looking Statements


This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.


Investor Relations Contact


Crescendo Communications, LLC

Tel: (212) 671-1021







The following information was filed by Smart For Life, Inc. (SMFL) on Monday, May 16, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Smart For Life, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Smart For Life, Inc..


Assess how Smart For Life, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Smart For Life, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools


Learn More
Bullish Bearish Neutral
Filter Sentiment:
Filter Category:
M & A
Filter Subcategory:
Inside Smart For Life, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parentheticals)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Changes In Stockholders??? Equity (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited) (Parentheticals)
Accounting Policies, By Policy (Policies)
Acquisitions (Details) - Schedule Of Acquisitions
Acquisitions (Details) - Schedule Of Acquisitions (Parentheticals)
Acquisitions (Tables)
Commitments And Contingencies
Concentrations Of Credit Risks
Concentrations Of Credit Risks (Details)
Debt (Details)
Debt (Details) - Schedule Of Debt
Debt (Details) - Schedule Of Debt (Parentheticals)
Debt (Details) - Schedule Of Future Contractual Maturities Of The Debt
Debt (Tables)
Description Of Business
Description Of Business (Details)
Fair Value Measurement
Fair Value Measurement (Details)
Fair Value Measurement (Details) - Schedule Of Changes In Fair Value Of The Company???S Level 3 Financial Liabilities
Fair Value Measurement (Tables)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Details) - Schedule Of Future Amortization
Intangible Assets (Details) - Schedule Of Intangible Assets
Intangible Assets (Tables)
Inventory (Details) - Schedule Of Inventory Consisted
Inventory (Tables)
Lease Commitments
Lease Commitments (Details)
Lease Commitments (Details) - Schedule Of Minimum Lease Payments Under The Operating Lease
Lease Commitments (Details) - Schedule Of Right Of Use Asset And Liability
Lease Commitments (Tables)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Details) - Schedule Of Property And Equipment
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details)
Stockholders' Equity
Stockholders' Equity (Details)
Stockholders' Equity (Details) - Schedule Of Option And Warrant
Stockholders' Equity (Details) - Schedule Of Options And Warrants Granted, Exercised, Forfeited And Outstanding
Stockholders' Equity (Tables)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)

Material Contracts, Statements, Certifications & more

Smart For Life, Inc. provided additional information to their SEC Filing as exhibits

Ticker: SMFL
CIK: 1851860
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-22-048178
Submitted to the SEC: Mon Aug 15 2022 5:47:14 PM EST
Accepted by the SEC: Mon Aug 15 2022
Period: Thursday, June 30, 2022
Industry: Medicinal Chemicals And Botanical Products

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: